Mirum Pharmaceuticals
(NASDAQ:MIRM)
$24.09
0.18[0.75%]
Last update: 2:27PM Get Real Time Here
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

Mirum Pharmaceuticals Stock (NASDAQ:MIRM), Quotes and News Summary

Mirum Pharmaceuticals Stock (NASDAQ: MIRM) stock price, news, charts, stock research, profile.

Open$24.190
Close-
Volume / Avg.152.325K / 540.676K
Day Range23.770 - 24.690
52 Wk Range23.760 - 35.560
Market Cap$1.132B
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
38
Short Interest
19.06%
Days to Cover15.18

Recent News

$5M Bet On Snowflake? Check Out These 4 Stocks Insiders Are Buying
Although U.S. stocks closed higher on Wednesday, there were a few notable insider trades.
Avi Kapoor
FDA Approves Mirum's Livmarli For Liver Disease In Kids As Young As 5 Years: Analyst Bullish On Label Expansion Strategy
FDA approves Livmarli by Mirum Pharmaceuticals for cholestatic pruritus in PFIC patients ≥5 years old. Data from Phase 3 MARCH study. Analysts bullish on broader coverage in 2024, with price target raised to $58. Concerns over age restrictions addressed with proposed new formulation."
Vandana Singh
Veradigm, Aehr Test Systems, Saratoga Investment And Other Big Stocks Moving Lower On Wednesday
U.S. stocks traded slightly higher, with the Dow Jones index gaining over 20 points on Wednesday. Shares of Veradigm Inc. (NASDAQ: MDRX) shares fell sharply during Wednesday’s session.
Avi Kapoor
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
2
Dec 23
0
0
0
0
Jan
2
Feb
4
Mar
1
Apr
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
4.5
Strong Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
About Mirum Pharmaceuticals Inc
Sector
Health Care
Industry
Biotechnology
Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition,...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
MIRM
MGNX

FAQ

Q

How do I buy Mirum Pharmaceuticals (MIRM) stock?

A

You can purchase shares of Mirum Pharmaceuticals (NASDAQ: MIRM) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Mirum Pharmaceuticals's (MIRM) competitors?

A

Other companies in Mirum Pharmaceuticals’s space includes: Macrogenics (NASDAQ:MGNX), Immunome (NASDAQ:IMNM), 4D Molecular Therapeutics (NASDAQ:FDMT), Zentalis Pharma (NASDAQ:ZNTL) and Centessa Pharmaceuticals (NASDAQ:CNTA).

Q

What is the target price for Mirum Pharmaceuticals (MIRM) stock?

A

The latest price target for Mirum Pharmaceuticals (NASDAQ: MIRM) was reported by HC Wainwright & Co. on Tuesday, April 2, 2024. The analyst firm set a price target for 58.00 expecting MIRM to rise to within 12 months (a possible 140.76% upside). 31 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Mirum Pharmaceuticals (MIRM)?

A

The stock price for Mirum Pharmaceuticals (NASDAQ: MIRM) is $24.09 last updated Today at April 16, 2024 at 2:27 PM EDT.

Q

Does Mirum Pharmaceuticals (MIRM) pay a dividend?

A

There are no upcoming dividends for Mirum Pharmaceuticals.

Q

When is Mirum Pharmaceuticals (NASDAQ:MIRM) reporting earnings?

A

Mirum Pharmaceuticals’s Q1 earnings are confirmed for Thursday, May 2, 2024.

Q

Is Mirum Pharmaceuticals (MIRM) going to split?

A

There is no upcoming split for Mirum Pharmaceuticals.

Q

What sector and industry does Mirum Pharmaceuticals (MIRM) operate in?

A

Mirum Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch